1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Point of Care Diagnostics Market – By Product

1.3.2        North America Point of Care Diagnostics Market – By Prescription Mode

1.3.3        North America Point of Care Diagnostics Market – By End User

1.3.4        North America Point of Care Diagnostics Market – By Country

2.           Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Point of Care Diagnostics Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

5.           North America Point of Care Diagnostics Market – Key Industry Dynamics

5.1         Key Market Drivers

5.1.1        Growing Prevalence of Infectious Diseases

5.1.2        Increasing Product Launches and Product Developments

5.1.3        Rising Number of CLIA-waived POC tests

5.2         Market Restraints

5.2.1        Product Recalls in Market

5.3         Market Opportunities

5.3.1        Burgeoning Number of Conferences and Events

5.4         Future Trends

5.4.1        Escalating Use of Home-Based POC Devices

5.5         Impact Analysis

6.           Point of Care Diagnostics Market – North America Analysis

6.1         North America Point of Care Diagnostics Market Revenue Forecast and Analysis

7.           North America Point of Care Diagnostics Market Analysis– by Product

7.1         Overview

7.2         North America Point of Care Diagnostics Market, By Product 2020 & 2028 (%)

7.3         Glucose Monitoring

7.3.1        Overview

7.3.2        Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)

7.4         Infectious Disease Testing

7.4.1        Overview

7.4.2        Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.3        HIV Testing

7.4.3.1          Overview

7.4.3.2          HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.4        Influenza Testing

7.4.4.1          Overview

7.4.4.2          Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.5        Sexually Transmitted Disease (STD) Testing

7.4.5.1          Overview

7.4.5.2          Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.6        Hepatitis C Testing

7.4.6.1          Overview

7.4.6.2          Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.7        Healthcare-Associated Infection (HAI) Testing

7.4.7.1          Overview

7.4.7.2          Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.8        Tropical Disease Testing

7.4.8.1          Overview

7.4.8.2          Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.9        Respiratory Infection Testing

7.4.9.1          Overview

7.4.9.2          Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.4.10     Other Infectious Disease

7.4.10.1       Overview

7.4.10.2       Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)

7.5         Cardiometabolic Testing

7.5.1        Overview

7.5.2        Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.6         Pregnancy and Fertility Testing

7.6.1        Overview

7.6.2        Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.7         Coagulation Testing

7.7.1        Overview

7.7.2        Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.8         Tumor/Cancer Marker Testing

7.8.1        Overview

7.8.2        Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.9         Cholesterol Testing

7.9.1        Overview

7.9.2        Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.10      Urinalysis Testing

7.10.1     Overview

7.10.2     Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)

7.11      Haematology Testing

7.11.1     Overview

7.11.2     Haematology Testing Revenue and Forecasts to 2028 (US$ Mn)

7.12      Other POC

7.12.1     Overview

7.12.2     Other POC Market Revenue and Forecasts to 2028 (US$ Mn)

8.           North America Point of Care Diagnostics Market Analysis– by Prescription Mode

8.1         Overview

8.2         North America Point of Care Diagnostics Market, By Prescription Mode 2020 & 2028 (%)

8.3         Prescription-Based Testing Market

8.3.1        Overview

8.3.2        Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)

8.4         OTC Testing Market

8.4.1        Overview

8.4.2        OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)

9.           North America Point of Care Diagnostics Market Analysis– by End User

9.1         Overview

9.2         North America Point of Care Diagnostics Market, By End User 2020 & 2028 (%)

9.3         Professional Diagnostic Centers

9.3.1        Overview

9.3.2        Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)

9.3.3        Hospitals

9.3.3.1          Overview

9.3.3.2          Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)

9.3.4        Clinical Laboratories

9.3.4.1          Overview

9.3.4.2          Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

9.3.5        Outpatient Healthcare

9.3.5.1          Overview

9.3.5.2          Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)

9.3.6        Ambulatory Care Settings

9.3.6.1          Overview

9.3.6.2          Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)

9.4         Home Care

9.4.1        Overview

9.4.2        Home Care Market Revenue and Forecasts to 2028 (US$ Mn)

9.5         Research Laboratories

9.5.1        Overview

9.5.2        Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

9.6         Others

9.6.1        Overview

9.6.2        Others Market Revenue and Forecasts to 2028 (US$ Mn)

10.        North America Point of Care Diagnostics Market – Country Analysis

10.1      North America: Point of Care Diagnostics Market

10.1.1     Overview

10.1.2     North America: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)

10.1.3     US: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

10.1.3.1       US: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

10.1.3.2       US: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)

10.1.3.2.1       US: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)

10.1.3.3       US: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)

10.1.3.4       US: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)

10.1.3.4.1       US: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)

10.1.4     Canada: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

10.1.4.1       Canada: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

10.1.4.2       Canada: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)

10.1.4.2.1       Canada: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)

10.1.4.3       Canada: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)

10.1.4.4       Canada: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)

10.1.4.4.1       Canada: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)

10.1.5     Mexico: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

10.1.5.1       Mexico: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

10.1.5.2       Mexico: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)

10.1.5.2.1       Mexico: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)

10.1.5.3       Mexico: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)

10.1.5.4       Mexico: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)

10.1.5.4.1       Mexico: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)

11.        Impact of COVID-19 Pandemic on North America Point of Care Diagnostics Market

11.1      North America: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Organic Growth Strategies

12.2.1     Overview

12.3      Inorganic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      F. HOFFMANN-LA ROCHE LTD.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Danaher

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      BIO-RAD LABORATORIES INC.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Abbott

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Johnson and Johnson Services, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Siemens AG

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      BD

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      bioMerieux SA

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Polymer Technology Systems, Inc. (PTS)

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Nova Biomedical

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

14.        Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

Table 1.             North America Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Table 2.             US: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)

Table 3.             US: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)

Table 4.             US: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)

Table 5.             US: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)

Table 6.             US: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)

Table 7.             Canada: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)

Table 8.             Canada: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)

Table 9.             Canada: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)

Table 10.          Canada: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)

Table 11.          Canada: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)

Table 12.          Mexico: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)

Table 13.          Mexico: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)

Table 14.          Mexico: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)

Table 15.          Mexico: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)

Table 16.          Mexico: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)

Table 17.          Recent Organic Developments the Point of Care Diagnostics Market

Table 18.          Recent Inorganic Developments in the Point of Care Diagnostics Market

Table 19.          Glossary of Terms

Figure 1.           North America Point of Care Diagnostics Market Segmentation

Figure 2.           North America Point of Care Diagnostics Market Segmentation, By Country

Figure 3.           North America Point of Care Diagnostics Market Overview

Figure 4.           Prescription-Based Testing Segment Held Largest Share of Point of North America Care Diagnostics Market

Figure 5.           US to Show Significant Growth During Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           Impact Analysis of Driver and Restraints Pertaining to North America Point of Care Diagnostics Market

Figure 8.           North America Point of Care Diagnostics Market – Revenue Forecast and Analysis

Figure 9.           North America Point of Care Diagnostics Market, by Products 2020 & 2028 (%)

Figure 10.        North America Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 11.        North America Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12.        North America HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13.        North America Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14.        North America Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 15.        North America Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16.        North America Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17.        North America Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 18.        North America Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19.        North America Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20.        North America Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21.        North America Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 22.        North America Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 23.        North America Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 24.        North America Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 25.        North America Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 26.        North America Haematology Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 27.        North America Other POC Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 28.        North America Point of Care Diagnostics Market, by Prescription Mode 2020 & 2028 (%)

Figure 29.        North America Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 30.        North America OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 31.        North America Point of Care Diagnostics Market, by End User 2020 & 2028 (%)

Figure 32.        North America Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 33.        North America Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 34.        North America Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 35.        North America Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 36.        North America Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 37.        North America Home Care Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 38.        North America Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 39.        North America Others Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 40.        North America: Point of Care Diagnostics Market, by Key Country- Revenue (2020) (USD Million)

Figure 41.        North America: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)

Figure 42.        US: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

Figure 43.        Canada: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)

Figure 44.        Mexico Point of care diagnostics Market Revenue and Forecast to 2028 (US$ Mn)

Figure 45.        Impact of COVID-19 Pandemic in North American Country Markets